Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v7-FR Version v3-FR
Language French French
Date Updated 2017-09-22 2017-03-31
Drug Identification Number 02148765 02148765
Brand name MYLAN-METFORMIN MYLAN-METFORMIN
Common or Proper name METFORMIN METFORMIN
Company Name MYLAN PHARMACEUTICALS ULC MYLAN PHARMACEUTICALS ULC
Ingredients METFORMIN HYDROCHLORIDE METFORMIN HYDROCHLORIDE
Strength(s) 500MG 500MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 100 100
ATC code A10BA A10BA
ATC description BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
Reason for shortage Disruption of the manufacture of the drug. Requirements related to complying with good manufacturing practices.
Anticipated start date
Actual start date 2017-03-16 2017-03-16
Estimated end date Unknown Unknown
Actual end date 2017-09-21
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Resolved as 100BT reported under ID 3935
Health Canada comments